Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News Feed

1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.

News 2026-09-01 06:30 UTC

EU approves Enhertu plus pertuzumab for HER2+ metastatic breast cancer

The EU has approved Enhertu plus pertuzumab as a new first-line regimen for patients with HER2-positive metastatic breast cancer.